UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 879

Sortiert nach

A pharmacological chaperone improves memory by reducing Aβ and tau neuropathology in a mouse model with plaques and tangles

Molecular neurodegeneration, 2020-01, Vol.15 (1), p.1-1, Article 1

2020

Volltextzugriff (PDF)

Targeting SARS-CoV‑2 M3CLpro by HCV NS3/4a Inhibitors: In Silico Modeling and In Vitro Screening

Journal of chemical information and modeling, 2021-02, Vol.61 (2), p.1020-1032

2021

Volltextzugriff (PDF)

Basic Principles of Drug Discovery and Development

Blass, Benjamin E

1, 2015

Volltextzugriff (PDF)

Pharmacology and Therapeutic Potential of the 5‑HT7 Receptor

ACS chemical neuroscience, 2019-01, Vol.10 (1), p.89-119

2019

Volltextzugriff (PDF)

5-HT1B receptor agonist enhances breakpoint for cocaine on a progressive ratio (PR) schedule during maintenance of self-administration in female rats but reduces breakpoint for sucrose

Frontiers in behavioral neuroscience, 2022-11, Vol.16, p.1020146-1020146

2022

Volltextzugriff (PDF)

On the road to obesity: Television viewing increases intake of high-density foods

Physiology & behavior, 2006-07, Vol.88 (4), p.597-604

2006

Volltextzugriff (PDF)

Correction to: A pharmacological chaperone improves memory by reducing Aβ and tau neuropathology in a mouse model with plaques and tangles

Molecular neurodegeneration, 2021-06, Vol.16 (1), p.1-42, Article 42

2021

Volltextzugriff (PDF)

Dysfunction of the retromer complex system contributes to amyloid and tau pathology in a stem cell model of Down syndrome

Alzheimer's & dementia : translational research & clinical interventions, 2022, Vol.8 (1), p.e12334-n/a

2022

Volltextzugriff (PDF)

Skin-to-skin contact is analgesic in healthy newborns

Pediatrics (Evanston), 2000-01, Vol.105 (1), p.e14

2000

Volltextzugriff (PDF)

Inhibitors of Na v 1.7 for the Treatment of Pain

ACS medicinal chemistry letters, 2022-04, Vol.13 (4), p.532-533

Blass, Benjamin E

2022

Volltextzugriff (PDF)

Inhibitors of Nav1.7 for the Treatment of Pain

ACS medicinal chemistry letters, 2022-04, Vol.13 (4), p.532-533

Blass, Benjamin E

2022

Volltextzugriff (PDF)

Cyclic ADP Ribose Hydrolase (CD38) Inhibitors

ACS medicinal chemistry letters, 2022-01, Vol.13 (1), p.13-14

Blass, Benjamin E

2022

Volltextzugriff (PDF)

Pyrrolo-pyridazine Derivatives as Muscarinic M 1 Receptor Positive Allosteric Modulators

ACS medicinal chemistry letters, 2021-05, Vol.12 (5), p.677-678

Blass, Benjamin E

2021

Volltextzugriff (PDF)

Pyrrolo-pyridazine Derivatives as Muscarinic M1 Receptor Positive Allosteric Modulators

ACS medicinal chemistry letters, 2021-05, Vol.12 (5), p.677-678

Blass, Benjamin E

2021

Volltextzugriff (PDF)

HIV gp120 impairs nucleus accumbens neuroimmune function and dopamine D3 receptor-mediated inhibition of cocaine seeking in male rats

Addiction neuroscience, 2023-03, Vol.5, p.100062, Article 100062

2023

Volltextzugriff (PDF)

2-Amino-N-heteroaryl-nicotimamides as Na v 1.8 Inhibitors

ACS medicinal chemistry letters, 2020-12, Vol.11 (12), p.2354-2356

Blass, Benjamin E

2020

Volltextzugriff (PDF)

Carboxamides as Modulators of Sodium Channels

ACS medicinal chemistry letters, 2020-12, Vol.11 (12), p.2364-2365

Blass, Benjamin E

2020

Volltextzugriff (PDF)

Novel Potassium Channel Inhibitors

ACS medicinal chemistry letters, 2020-12, Vol.11 (12), p.2357-2358

Blass, Benjamin E

2020

Volltextzugriff (PDF)

2‑Amino-N-heteroaryl-nicotimamides as Nav1.8 Inhibitors

ACS medicinal chemistry letters, 2020-12, Vol.11 (12), p.2354-2356

Blass, Benjamin E

2020

Volltextzugriff (PDF)

Beneficial Effect of a Small Pharmacologic Chaperone on the Established Alzheimer's Disease Phenotype

Journal of Alzheimer's disease, 2023-01, Vol.91 (1), p.463

2023

Volltextzugriff (PDF)

The Long-Acting D3 Partial Agonist MC-25-41 Attenuates Motivation for Cocaine in Sprague-Dawley Rats

Biomolecules (Basel, Switzerland), 2020-07, Vol.10 (7), p.1076

2020

Volltextzugriff (PDF)

12/15-Lipoxygenase Inhibition Reverses Cognitive Impairment, Brain Amyloidosis, and Tau Pathology by Stimulating Autophagy in Aged Triple Transgenic Mice

Biological psychiatry (1969), 2017-01, Vol.81 (2), p.92-100

2017

Volltextzugriff (PDF)

Novel druggable mechanism of Parkinson's disease: Potential therapeutics and underlying pathogenesis based on ferroptosis

Medicinal research reviews, 2023-07, Vol.43 (4), p.872-896

2023

Volltextzugriff (PDF)

Triazolo-azepine Inhibitors of γ‑Secretase and Their Methods of Use

ACS medicinal chemistry letters, 2019-09, Vol.10 (9), p.1243-1244

Blass, Benjamin E

2019

Volltextzugriff (PDF)

Modulators of KEAP‑1 Activity as Potential Therapies for the Treatment of Neurodegenerative Disorders

ACS medicinal chemistry letters, 2019-09, Vol.10 (9), p.1245-1246

Blass, Benjamin E

2019

Volltextzugriff (PDF)

1 – 25 von 879

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(661)
Mit Volltextzugriff
(670)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(369)
Life Sciences & Biomedicine
(267)
Animals
(191)
Humans
(144)
Female
(132)
Biological And Medical Sciences
(113)
Rats
(110)
Male
(107)
Neurosciences & Neurology
(82)
Neurosciences
(70)
Social Sciences
(67)
Psychology
(60)
Fundamental And Applied Biological Sciences. Psychology
(59)
Physical Sciences
(58)
Technology
(57)
Exact Sciences And Technology
(56)
Medical Sciences
(55)
Biochemistry & Molecular Biology
(52)
Pharmacology & Pharmacy
(49)
Psychology. Psychoanalysis. Psychiatry
(41)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A pharmacological chaperone improves memory by reducing Aβ and tau neuropathology in a mouse model with plaques and tangles

Targeting SARS-CoV‑2 M3CLpro by HCV NS3/4a Inhibitors: In Silico Modeling and In Vitro Screening

Basic Principles of Drug Discovery and Development

Pharmacology and Therapeutic Potential of the 5‑HT7 Receptor

5-HT1B receptor agonist enhances breakpoint for cocaine on a progressive ratio (PR) schedule during maintenance of self-administration in female rats but reduces breakpoint for sucrose

On the road to obesity: Television viewing increases intake of high-density foods

Correction to: A pharmacological chaperone improves memory by reducing Aβ and tau neuropathology in a mouse model with plaques and tangles

Dysfunction of the retromer complex system contributes to amyloid and tau pathology in a stem cell model of Down syndrome

Skin-to-skin contact is analgesic in healthy newborns

Inhibitors of Na v 1.7 for the Treatment of Pain

Inhibitors of Nav1.7 for the Treatment of Pain

Cyclic ADP Ribose Hydrolase (CD38) Inhibitors

Pyrrolo-pyridazine Derivatives as Muscarinic M 1 Receptor Positive Allosteric Modulators

Pyrrolo-pyridazine Derivatives as Muscarinic M1 Receptor Positive Allosteric Modulators

HIV gp120 impairs nucleus accumbens neuroimmune function and dopamine D3 receptor-mediated inhibition of cocaine seeking in male rats

2-Amino-N-heteroaryl-nicotimamides as Na v 1.8 Inhibitors

Carboxamides as Modulators of Sodium Channels

Novel Potassium Channel Inhibitors

2‑Amino-N-heteroaryl-nicotimamides as Nav1.8 Inhibitors

Beneficial Effect of a Small Pharmacologic Chaperone on the Established Alzheimer's Disease Phenotype

The Long-Acting D3 Partial Agonist MC-25-41 Attenuates Motivation for Cocaine in Sprague-Dawley Rats

12/15-Lipoxygenase Inhibition Reverses Cognitive Impairment, Brain Amyloidosis, and Tau Pathology by Stimulating Autophagy in Aged Triple Transgenic Mice

Novel druggable mechanism of Parkinson's disease: Potential therapeutics and underlying pathogenesis based on ferroptosis

Triazolo-azepine Inhibitors of γ‑Secretase and Their Methods of Use

Modulators of KEAP‑1 Activity as Potential Therapies for the Treatment of Neurodegenerative Disorders

Suchergebnisse filtern